Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: AJR Am J Roentgenol. 2020 Oct 14;217(3):720–729. doi: 10.2214/AJR.20.24509

Fig. 5—

Fig. 5—

Scatterplot illustrates changes in SUVmax of prostatic lesion versus serum PSA level in men before (within red outline) and after (within green outline) undergoing neoadjuvant androgen deprivation therapy.